For: | Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001; 7(2): 208-215 [PMID: 11819762 DOI: 10.3748/wjg.v7.i2.208] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i2/208.htm |
Number | Citing Articles |
1 |
Christian Rabe, Matthias Lenz, Volker Schmitz, Tillmann Pilz, Rolf Fimmers, Tilman Sauerbruch, Wolfgang H Caselmann. An independent evaluation of modern prognostic scores in a central European cohort of 120 patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2003; 15(12): 1305 doi: 10.1097/00042737-200312000-00009
|
2 |
Dao-Xiong Lei, Cheng-Hong Peng, Shu-You Peng, Xian-Chuan Jiang, Yu-Lian Wu, Hong-Wei Shen. Safe upper limit of intermittent hepatic inflow occlusion for liver resection in cirrhotic rats. World Journal of Gastroenterology 2001; 7(5): 713-717 doi: 10.3748/wjg.v7.i5.713
|
3 |
|
4 |
Mohammad Atiqur Rahman, Ioannis D. Kyriazanos, Takashi Ono, Akira Yamanoi, Hitoshi Kohno, Mikako Tsuchiya, Naofumi Nagasue. Impact of PTEN expression on the outcome of hepatitis C virus‐positive cirrhotic hepatocellular carcinoma patients: Possible relationship with COX II and inducible nitric oxide synthase. International Journal of Cancer 2002; 100(2): 152 doi: 10.1002/ijc.10458
|
5 |
Li-Fen Gao, Wen-Sheng Sun, Chun-Hong Ma, Su-Xia Liu, Xiao-Yan Wang, Li-Ning Zhang, Ying-Lin Cao, Fa-Liang Zhu, Yu-Gang Liu. Establishment of mice model with human viral hepatitis B. World Journal of Gastroenterology 2004; 10(6): 841-846 doi: 10.3748/wjg.v10.i6.841
|
6 |
Sahaj Rathi, Radha K. Dhiman. GI Surgery Annual. GI Surgery Annual 2015; 22: 135 doi: 10.1007/978-981-10-2010-0_7
|
7 |
Zhao-Chong Zeng, Guo-Liang Jiang, Guo-Min Wang, Zhao-You Tang, Walter J. Curran, George Iliakis. DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line. World Journal of Gastroenterology 2002; 8(5): 797-803 doi: 10.3748/wjg.v8.i5.797
|
8 |
Chi-Hang Wong, Sophie Ka-Ping Chan, Henry Lik-Yuen Chan, Stephen Kwok-Wing Tsui. The Molecular Diagnosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Critical Reviews in Clinical Laboratory Sciences 2006; 43(1): 69 doi: 10.1080/10408360500410407
|
9 |
Jing-Song Chen, Qian Wang, Xi-Lin Chen, Xiao-Hui Huang, Li-Jian Liang, Jian Lei, Jiong-Qiang Huang, Dong-Ming Li, Zhi-Xiang Cheng. Clinicopathologic Characteristics and Surgical Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Journal of Surgical Research 2012; 175(2): 243 doi: 10.1016/j.jss.2011.03.072
|
10 |
Zheng-Hua Lu, Feng Shen, Zhen-Lin Yan, Jun Li, Jia-He Yang, Ming Zong, Le-Hua Shi, Meng-Chao Wu. Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation. Journal of Cancer Research and Clinical Oncology 2009; 135(6): 783 doi: 10.1007/s00432-008-0513-0
|
11 |
F. Alconchel, L.A. Martínez-Insfran, P.A. Cascales-Campos, B. Febrero, L. Martínez-Alarcón, A. Ríos, J.A. Fernández-Hernández, J.M. Rodríguez, G. Ruiz-Merino, M. Royo-Villanova, J.A. Pons, R. Robles-Campos, F. Sánchez-Bueno, P. Ramírez, P. Parrilla. Impact of Hepatic Artery Thrombosis on the Success of a Liver Transplant Because of Hepatocellular Carcinoma. Transplantation Proceedings 2020; 52(2): 559 doi: 10.1016/j.transproceed.2019.11.037
|
12 |
Dmitri Bezinover, Molly F. Deacutis, Priti G. Dalal, Robert P. Moore, Jonathan G. Stine, Ming Wang, Ethan Reeder, Christopher S. Hollenbeak, Fuat H. Saner, Thomas R. Riley, Piotr K. Janicki. Perioperative thrombotic complications associated with pediatric liver transplantation: a UNOS database evaluation. HPB 2019; 21(3): 370 doi: 10.1016/j.hpb.2018.08.014
|
13 |
Jendrik Becker-Assmann, Mohammad H. Fard-Aghaie, Alexandros Kantas, Georgios Makridis, Tim Reese, Kim C. Wagner, Jörg Petersen, Peter Buggisch, Axel Stang, Thomas von Hahn, Karl J. Oldhafer. Diagnostische und prognostische Bedeutung des α-Feto-Proteins beim hepatozellulären Karzinom. Der Chirurg 2020; 91(9): 769 doi: 10.1007/s00104-020-01118-6
|
14 |
Aldo Spadaro, Antonino Ajello, Carmela Morace, Agata Zirilli, Graziella D’arrigo, Carmelo Luigiano, Francesco Martino, Anna Bene, Domenico Migliorato, Santi Turiano, Oscar Ferraù, Maria Antonietta Freni. Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits. World Journal of Gastroenterology 2005; 11(13): 1987-1990 doi: 10.3748/wjg.v11.i13.1987
|
15 |
Vikrom K. Dhar, Shimul A. Shah. Primary and Metastatic Liver Tumors. 2018; : 45 doi: 10.1007/978-3-319-91977-5_4
|
16 |
T F Greten, F Papendorf, J S Bleck, T Kirchhoff, T Wohlberedt, S Kubicka, J Klempnauer, M Galanski, M P Manns. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. British Journal of Cancer 2005; 92(10): 1862 doi: 10.1038/sj.bjc.6602590
|
17 |
Janaki Amin, Dianne O'Connell, Mark Bartlett, Elizabeth Tracey, John Kaldor, Matthew Law, Gregory Dore. Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study. Australian and New Zealand Journal of Public Health 2007; 31(5): 475 doi: 10.1111/j.1753-6405.2007.00121.x
|
18 |
Mohammad F. Madhoun, Javid Fazili, Ted Bader, David N. Roberts, Brianna C. Bright, Michael S. Bronze. Hepatitis C Prevalence in Patients With Hepatocellular Carcinoma Without Cirrhosis. The American Journal of the Medical Sciences 2010; 339(2): 169 doi: 10.1097/MAJ.0b013e3181c4af27
|
19 |
Min-Shan Chen, Jin-Qing Li, Ya-Qi Zhang, Li-Xia Lu, Wei-Zhang Zhang, Yun-Fei Yuan, Yong-Ping Guo, Xiao-Jun Lin, Guo-Hui Li. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(1): 74-78 doi: 10.3748/wjg.v8.i1.74
|
20 |
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
|
21 |
Jennifer Ng, Jennifer Wu. Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences. Hepatitis Monthly 2012; 12(10 HCC) doi: 10.5812/hepatmon.7635
|
22 |
Wen-He Zhao, Zhi-Min Ma, Xing-Ren Zhou, Yi-Zheng Feng, Bao-Shan Fang. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World Journal of Gastroenterology 2002; 8(2): 237-242 doi: 10.3748/wjg.v8.i2.237
|
23 |
T Malek Mahmoudi, Vladimir Marquez, Ahmed Kayal, Rebecca Carvalho, Alan A Weiss. HCC complicated by PVT: Outcome and the role of anticoagulation therapy. Canadian Liver Journal 2019; 2(3): 121 doi: 10.3138/canlivj.2018-0026
|
24 |
X.-W. Wan, M. Jiang, H.-F. Cao, Y.-Q. He, S.-Q. Liu, X.-H. Qiu, M.-C. Wu, H.-Y. Wang. The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2003; 129(2): 100 doi: 10.1007/s00432-002-0410-x
|
25 |
Gregory C. Connolly, Rui Chen, Ollivier Hyrien, Parvez Mantry, Adel Bozorgzadeh, Peter Abt, Alok A. Khorana. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thrombosis Research 2008; 122(3): 299 doi: 10.1016/j.thromres.2007.10.009
|
26 |
WILLIAM KEMP, STEPHEN PIANKO, SHARA NGUYEN, MICHAEL J BAILEY, STUART K ROBERTS. Survival in hepatocellular carcinoma: Impact of screening and etiology of liver disease. Journal of Gastroenterology and Hepatology 2005; 20(6): 873 doi: 10.1111/j.1440-1746.2005.03844.x
|
27 |
Sylvie Deuffic–Burban, Pierre Deltenre, Maria Buti, Tommaso Stroffolini, Julie Parkes, Nikolai Mühlberger, Uwe Siebert, Christophe Moreno, Angelos Hatzakis, William Rosenberg, Stefan Zeuzem, Philippe Mathurin. Predicted Effects of Treatment for HCV Infection Vary Among European Countries. Gastroenterology 2012; 143(4): 974 doi: 10.1053/j.gastro.2012.05.054
|
28 |
Tong-Dong Shi, Yu-Zhang Wu, Zheng-Cai Jia, Li-Yun Zou, Wei Zhou. Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD<sub>8</sub><sup>+</sup> CTL-mediated cytotoxicity in HLA-A2<sup>+</sup> human PBMCs. World Journal of Gastroenterology 2004; 10(13): 1902-1906 doi: 10.3748/wjg.v10.i13.1902
|
29 |
Dmitri Bezinover, Khaled Iskandarani, Vernon Chinchilli, Patrick McQuillan, Fuat Saner, Zakiyah Kadry, Thomas R. Riley, Piotr K. Janicki. Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis. BMC Anesthesiology 2015; 16(1) doi: 10.1186/s12871-016-0192-3
|
30 |
Rebecca Toonkel, Aimee Zaas. Cases from the Osler Medical Service at Johns Hopkins University. The American Journal of Medicine 2003; 115(6): 497 doi: 10.1016/j.amjmed.2003.08.005
|
31 |
Run-Zhou Ni, Jie-Fei Huang, Ming-Bing Xiao, Mei Li, Xian-Yong Meng. Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(4): 710-713 doi: 10.3748/wjg.v9.i4.710
|
32 |
Lian-Jun Yang, Wen-Liang Wang. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization. World Journal of Gastroenterology 2002; 8(5): 808-814 doi: 10.3748/wjg.v8.i5.808
|
33 |
Zhao-Chong Zeng, Qian-Qian Zhao. Radiotherapy of Liver Cancer. 2021; : 225 doi: 10.1007/978-981-16-1815-4_17
|
34 |
Tian-Tian Wu, Hu-Cheng Li, Fang Zheng, Guo-Kun Ao, Hu Lin, Wei-Min Li. Percutaneous Endovascular Radiofrequency Ablation for Malignant Portal Obstruction: An Initial Clinical Experience. CardioVascular and Interventional Radiology 2016; 39(7): 994 doi: 10.1007/s00270-016-1317-2
|
35 |
Mineto Ohta, Chikashi Nakanishi, Naoki Kawagishi, Yasuyuki Hara, Kai Maida, Toshiaki Kashiwadate, Koji Miyazawa, Satoru Yoshida, Shigehito Miyagi, Yukihiro Hayatsu, Shunsuke Kawamoto, Yasushi Matsuda, Yoshinori Okada, Yoshikatsu Saiki, Noriaki Ohuchi. Surgical resection of recurrent extrahepatic hepatocellular carcinoma with tumor thrombus extending into the right atrium under cardiopulmonary bypass: a case report and review of the literature. Surgical Case Reports 2016; 2(1) doi: 10.1186/s40792-016-0241-7
|
36 |
Bingjun Qian, Huifeng Shen, Jingjing Xiong, Li Chen, Lu Zhang, Junwei Jia, Yuan Wang, Zhuchuan Zhang, Zheng Yuan, Kaiming Cao, Dabing Zhang. Expression and purification of the synthetic preS1 gene of Hepatitis B Virus with preferred Escherichia coli codon preference. Protein Expression and Purification 2006; 48(1): 74 doi: 10.1016/j.pep.2005.11.024
|
37 |
Cho Naing, Han Ni, Htar Htar Aung. Tamoxifen for adults with hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2024; 2024(8) doi: 10.1002/14651858.CD014869.pub2
|
38 |
Atsushi Kudo, Shinji Tanaka, Daisuke Ban, Satoshi Matsumura, Takumi Irie, Takanori Ochiai, Noriaki Nakamura, Shigeki Arii, Minoru Tanabe. Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis. Journal of Gastroenterology 2014; 49(9): 1352 doi: 10.1007/s00535-013-0899-6
|
39 |
Y-R Deng, K Yoshida, Q L Jin, M Murata, T Yamaguchi, K Tsuneyama, Y Moritoki, J Q Niu, K Matsuzaki, Z-X Lian. Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. Clinical and Experimental Immunology 2014; 176(1): 102 doi: 10.1111/cei.12259
|
40 |
Yong Li, You-Yong Lu. Applying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cells. World Journal of Gastroenterology 2002; 8(2): 213-216 doi: 10.3748/wjg.v8.i2.213
|
41 |
Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, Jian Zhou, Lun-Xiu Qin, Jian-Hua Wang, Hui-Chuan Sun, Bin-Liang Wang, Jian-Ying Zhang, Guo-Liang Jiang, Yu-Qi Wang. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. International Journal of Radiation Oncology*Biology*Physics 2005; 61(2): 432 doi: 10.1016/j.ijrobp.2004.05.025
|
42 |
Anna K NOWAK, Jonathan CEBON, Carol HARGREAVES, Haryana DHILLON, Michael FINDLAY, Val GEBSKI, Martin R STOCKLER. Assessment of health‐related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 2008; 4(1): 55 doi: 10.1111/j.1743-7563.2008.00142.x
|
43 |
Yagil Barazani, Jonathan R. Hiatt, Myron J. Tong, Ronald W. Busuttil. Chronic Viral Hepatitis and Hepatocellular Carcinoma. World Journal of Surgery 2007; 31(6): 1245 doi: 10.1007/s00268-007-9041-3
|
44 |
Quan-Cheng Kan, Zu-Jiang Yu, Yan-Chang Lei, Lian-Jie Hao, Dong-Liang Yang. Lethiferous effects of a recombinant vector carrying thymidine kinase suicide gene on 2.2.15 cells <italic>via</italic> a self-modulating mechanism. World Journal of Gastroenterology 2003; 9(10): 2216-2220 doi: 10.3748/wjg.v9.i10.2216
|
45 |
Guang-Jin Yuan, Ming-Liang Zhang, Zuo-Jiong Gong. Effects of PPARg agonist pioglitazone on rat hepatic fibrosis. World Journal of Gastroenterology 2004; 10(7): 1047-1051 doi: 10.3748/wjg.v10.i7.1047
|
46 |
Timothy R. Morgan, Sarathy Mandayam, M. Mazen Jamal. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127(5): S87 doi: 10.1053/j.gastro.2004.09.020
|
47 |
Edoardo Giovanni Giannini, Domenico Risso, Roberto Testa, Franco Trevisani, Maria Anna Di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Gian Ludovico Rapaccini, Fabio Farinati, Marco Zoli, Franco Borzio, Eugenio Caturelli. Prevalence and Prognostic Significance of the Presence of Esophageal Varices in Patients With Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2006; 4(11): 1378 doi: 10.1016/j.cgh.2006.08.011
|
48 |
Syed Abdul Basit, Christian D. Stone, Robert Gish. Portal Vein Thrombosis. Clinics in Liver Disease 2015; 19(1): 199 doi: 10.1016/j.cld.2014.09.012
|
49 |
Li-Wang Zhang, Jun Ren, Liang Zhang, Hong-Mei Zhang, Bin Jin, Bo-Rong Pan, Xiao-Ming Si, Yan-Jun Zhang, Zhong-Hua Wang, Yang-Lin Pan, Stephen M Festein. Construction and expression of recombined human AFP eukaryotic expression vector. World Journal of Gastroenterology 2003; 9(7): 1465-1468 doi: 10.3748/wjg.v9.i7.1465
|
50 |
Paul F. Lambert, Bill Sugden. Abeloff's Clinical Oncology. 2014; : 154 doi: 10.1016/B978-1-4557-2865-7.00011-4
|
51 |
S. Kubicka. Disease Progression and Disease Prevention in Hepatology and Gastroenterology. Falk Symposium 2006; 150: 238 doi: 10.1007/1-4020-5224-3_23
|
52 |
David E Kaplan, K.Rajender Reddy. Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes. Clinics in Liver Disease 2003; 7(3): 683 doi: 10.1016/S1089-3261(03)00060-6
|
53 |
Yantong Guo, Jingming Zhao, Jingtao Bi, Quan Wu, Xin Wang, Quanyou Lai. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early Hepatocellular carcinoma in patients with cirrhosis. Journal of Hematology & Oncology 2012; 5(1) doi: 10.1186/1756-8722-5-37
|
54 |
Antonio Díaz Sánchez, Óscar Núñez Martínez, Marisa Prieto Martín, Inmaculada Beceiro Pedreño, Javier Calleja Kempin, Leandro Santos Castro, Avertano Muro de la Fuente, Gerardo Clemente Ricote, Ana Matilla Peña. Factores pronósticos en pacientes con carcinoma hepatocelular desestimado para tratamiento. Gastroenterología y Hepatología 2007; 30(8): 441 doi: 10.1157/13110488
|
55 |
Jian-Min Huang, Tian-Hua Huang, Huan-Ying Qiu, Xiao-Wu Fang, Tian-Gang Zhuang, Hong-Xi Liu, Yong-Hua Wang, Li-Zhi Deng, Jie-Wen Qiu. Effects of hepatitis B virus infection on human sperm chromosomes. World Journal of Gastroenterology 2003; 9(4): 736-740 doi: 10.3748/wjg.v9.i4.736
|
56 |
Lun-Xiu Qin, Zhao-You Tang. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(2): 193-199 doi: 10.3748/wjg.v8.i2.193
|
57 |
Cui-Ping Zhang, Zi-Bin Tian, Xi-Shuang Liu, Qing-Xi Zhao, Jun Wu, Yong-Xin Liang. Effects of <i>zhaoyangwan</i> on chronic hepatitis B and posthepatic cirrhosis. World Journal of Gastroenterology 2004; 10(2): 295-298 doi: 10.3748/wjg.v10.i2.295
|
58 |
Antonio Giorgio, Antonella Di Sarno, Giorgio de Stefano, Nunzia Farella, Umberto Scognamiglio, Manuela de Stefano, Valentina Giorgio. Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus?. American Journal of Roentgenology 2009; 193(4): 948 doi: 10.2214/AJR.08.2087
|
59 |
Young Kim, Christopher C. Stahl, Abouelmagd Makramalla, Olugbenga O. Olowokure, Ross L. Ristagno, Vikrom K. Dhar, Michael R. Schoech, Seetharam Chadalavada, Tahir Latif, Jordan Kharofa, Khurram Bari, Shimul A. Shah. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. Surgery 2017; 162(6): 1250 doi: 10.1016/j.surg.2017.08.007
|
60 |
Feng Han, Yu-Fei Zhang, Yun-Qing Li. Fos expression in tyrosine hydroxylase-containing neurons in rat brainstem after visceral noxious stimulation: an immunohistochemical study. World Journal of Gastroenterology 2003; 9(5): 1045-1050 doi: 10.3748/wjg.v9.i5.1045
|
61 |
Paul F. Lambert, Bill Sugden. Abeloff's Clinical Oncology. 2020; : 165 doi: 10.1016/B978-0-323-47674-4.00012-8
|
62 |
Jun-Fei Jin, Liu-Di Yuan, Li Liu, Zhu-Jiang Zhao, Wei Xie. Preparation and characterization of polyclonal antibodies against ARL-1 protein. World Journal of Gastroenterology 2003; 9(7): 1455-1459 doi: 10.3748/wjg.v9.i7.1455
|
63 |
Lian-Xin Liu, Zhi-Hua Liu, Hong-Chi Jiang, Wei-Hui Zhang, Shu-Yi Qi, Jie Hu, Xiu-Qin Wang, Min Wu. Gene expression profiles of hepatoma cell line HLE. World Journal of Gastroenterology 2003; 9(4): 683-687 doi: 10.3748/wjg.v9.i4.683
|
64 |
Wu Ji, Jie-Shou Li, Ling-Tang Li, Wu-Hong Liu, Kuan-Sheng Ma, Xiang-Tian Wang, Zhen-Ping He, Jia-Hong Dong. Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(8): 1702-1706 doi: 10.3748/wjg.v9.i8.1702
|
65 |
Paul F. Lambert, Bill Sugden. Abeloff's Clinical Oncology. 2008; : 153 doi: 10.1016/B978-0-443-06694-8.50014-2
|
66 |
Petr Pancoska, Brian I. Carr, Robert A. Branch. Network-Based Analysis of Survival for Unresectable Hepatocellular Carcinoma. Seminars in Oncology 2010; 37(2): 170 doi: 10.1053/j.seminoncol.2010.03.008
|
67 |
Arash Sarveazad, Shahram Agah, Asrin Babahajian, Naser Amini, Mansour Bahardoust. Predictors of 5 year survival rate in hepatocellular carcinoma patients. Journal of Research in Medical Sciences 2019; 24(1): 86 doi: 10.4103/jrms.JRMS_1017_18
|
68 |
V. T. T. Nguyen, M. G. Law, G. J. Dore. Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden. Journal of Viral Hepatitis 2009; 16(7): 453 doi: 10.1111/j.1365-2893.2009.01117.x
|
69 |
Anastasios Roussos, Constantin Goritsas, Thomas Pappas, Maria Spanaki, Panagiota Papadaki, Angeliki Ferti. Prevalence of hepatitis B and C markers among refugees in Athens. World Journal of Gastroenterology 2003; 9(5): 993-995 doi: 10.3748/wjg.v9.i5.993
|
70 |
Tong-Dong Shi, Yu-Zhang Wu, Zheng-Cai Jia, Wei Zhou, Li-Yun Zou. Therapeutic polypeptides based on HBcAg<sub>18-27</sub> CTL epitope can induce antigen-specific CD<sub>8</sub><sup>+</sup> CTL-mediated cytotoxicity in HLA-A2 transgenic mice. World Journal of Gastroenterology 2004; 10(8): 1222-1226 doi: 10.3748/wjg.v10.i8.1222
|
71 |
CHUNPING WANG, YINYING LU, HONG WANG, XUDONG GAO, WENLIN BAI, JIANHUI QU, GUILIN XU, ZHENZHEN ZHANG, ZHEN ZENG, LIN ZHOU, LINJING AN, JIYUN LV, YONGPING YANG. Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine 2012; 4(2): 188 doi: 10.3892/etm.2012.569
|
72 |
Ida Martinelli, Francesca R. Ponziani, Alberto Maino, Sherrie Bhoori, Maria Abbattista, Umberto Maggi, Tullia M. De Feo, Paolo Bucciarelli, Andrea Artoni, Elena Longhi, Marta Serafini, Giorgio Rossi, Vincenzo Mazzaferro, Ferruccio Bonino. Thrombosis after liver transplantation for hepatocellular carcinoma. PLOS ONE 2017; 12(10): e0186699 doi: 10.1371/journal.pone.0186699
|
73 |
Walaa Abdelhamed, Hend Shousha, Mohamed El-Kassas. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?. Liver Research 2024; 8(3): 141 doi: 10.1016/j.livres.2024.09.002
|
74 |
Van TT Nguyen, Janaki Amin, Matthew G Law, Gregory J Dore. Predictors and survival in hepatitis B‐related hepatocellular carcinoma in New South Wales, Australia. Journal of Gastroenterology and Hepatology 2009; 24(3): 436 doi: 10.1111/j.1440-1746.2008.05577.x
|
75 |
Mahmut Yasen, Hiroshi Mizushima, Kaoru Mogushi, Gulanbar Obulhasim, Ken Miyaguchi, Kazuhiko Inoue, Izumi Nakahara, Tsutomu Ohta, Arihiro Aihara, Shinji Tanaka, Shigeki Arii, Hiroshi Tanaka. Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue. Cancer Science 2009; 100(3): 472 doi: 10.1111/j.1349-7006.2008.01068.x
|
76 |
Xiao-Fang Liu, Sheng-Quan Zou, Fa-Zu Qiu. Construction of HCV-core gene vector and its expression in cholangiocarcinoma. World Journal of Gastroenterology 2002; 8(1): 135-138 doi: 10.3748/wjg.v8.i1.135
|
77 |
V. Schmitz, T. Sauerbruch. Früherkennung des hepatozellulären Karzinoms. Der Gastroenterologe 2007; 2(5): 356 doi: 10.1007/s11377-007-0104-7
|